Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.480
0.00 (0.00%)
At close: Aug 28, 2025, 4:00 PM
1.340
-0.140 (-9.46%)
After-hours: Aug 28, 2025, 7:59 PM EDT

Telomir Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-16.08-16.53-13.07-0.85-0.14
Other Amortization
-4.341.61--
Stock-Based Compensation
12.916.87---
Other Operating Activities
-0-7.49--
Change in Accounts Payable
-0.140.180.110.390.02
Change in Other Net Operating Assets
0.01-0.06-0--
Operating Cash Flow
-3.17-5.07-3.86-0.47-0.12
Short-Term Debt Issued
--3.120.460.12
Total Debt Issued
-0.13-3.120.460.12
Short-Term Debt Repaid
--0.53---
Total Debt Repaid
-0.43-0.53---
Net Debt Issued (Repaid)
-0.57-0.533.120.460.12
Issuance of Common Stock
2.096.8710.06-
Other Financing Activities
0.52--0.26-0.05-
Financing Cash Flow
2.046.343.860.470.12
Net Cash Flow
-1.131.26-00-
Levered Free Cash Flow
2.841.1-1.96--
Unlevered Free Cash Flow
2.84-0.53-2.55--
Change in Working Capital
-0.130.130.110.390.02
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q